The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes

Rheumatology International

Volumn 25, Issue 8, 2005, Pages 625-630

  Kusabe, Takuma ^a   Waguri Nagaya, Yuko ^a   Tanikawa, Tomohiro ^a   Aoyama, Mineyoshi ^a   Fukuoka, Muneyoshi ^a   Kobayashi, Masaaki ^a   Otsuka, Takanobu ^a   Asai, Kiyofumi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Aurothioglucose; Disease modifying anti rheumatic drugs; Fibroblast like synoviocytes; Gliostatin; Interleukin 1 ; Platelet derived endothelial cell growth factor

Indexed keywords

AUROTHIOGLUCOSE; DEXAMETHASONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; MESSENGER RNA; METHOTREXATE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; SYNOVIOCYTE;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELLS; CELLS, CULTURED; CYSTEINE; DEXAMETHASONE; ELBOW; FEMALE; FIBROBLASTS; HUMANS; KNEE; METHOTREXATE; MIDDLE AGED; ORGANOGOLD COMPOUNDS; ORTHOPEDIC PROCEDURES; PENICILLAMINE; PHENYLACETATES; SULFASALAZINE; SYNOVIAL MEMBRANE; THYMIDINE PHOSPHORYLASE;

EID: 26244431745     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0624-8     Document Type: Article

References (31)

1. Paleolog EM (1996) Angiogenesis: a critical process in the pathogenesis of RA - a role for VEGF? Br J Rheumatol 35:917-919
2. Szekanecz Z, Koch AE, Kunkel SL, Strieter RM (1998) Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention. Drugs Aging 12:377-390
3. Asai K, Hirano T, Matsukawa K, Kusada J, Takeuchi M, Otsuka T, Matsui N, Kato T (1993) High concentration of immunoreactive gliostatin/platelet-derived endothelial cell growth factor in synovial fluid and serum of rheumatoid arthritis. Clin Chim Acta 218:1-4
4. Takeuchi M, Otsuka T, Matsui N, Asai K, Hirano T, Moriyama A, Isobe I, Eksioglu YZ, Matsukawa K, Kato T, Tada T (1994) Aberrant production of gliostatin/platelet-derived endothelial cell growth factor in rheumatoid arthritis. Arthritis Rheum 37:662-672
5. Waguri Y, Otsuka T, Sugimura I, Matsui N, Asai K, Moriyama A, Kato T (1997) Gliostatin/platelet-derived endothelial cell growth factor as a clinical marker of rheumatoid arthritis and its regulation in fibroblast like synoviocytes. Br J Rheumatol 36:315-321
6. Muro H, Waguri-Nagaya Y, Mukofujiwara Y, Iwahashi T, Otsuka T, Matsui N, Moriyama A, Asai K, Kato T (1999) Autocrine induction of gliostatin/platelet- derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes. Rheumatol 38:1195-1202
7. Waguri-Nagaya Y, Otsuka T, Sugimura I, Matsui N, Asai K, Nakajima K, Tada T, Akiyama S, Kato T (2000) Synovial inflammation and hyperplasia induced by gliostatin/ platelet-derived endothelial cell growth factor in rabbit knees. Rheumatol Int 20:13-19
8. Ishikawa F, Miyazono K, Hellman U, Drexler D, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557-562
9. Moghaddam A, Zhang H-T, Fan T-P, Hu D-E, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92:998-1002
10. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y, Akiyama S (1995) Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 55:1687-1690
11. Asai K, Hirano T, Kaneko S, Moriyama A, Nakanishi K, Isobe I, Eksioglu YZ, Kato T (1992) A novel glial growth inhibitory factor, gliostatin, derived from neurofibroma. J Neurochem 59:307-317
12. Asai K, Nakanishi K, Isobe I, Eksioglu YZ, Hirano T, Hama K, Miyamoto T, Kato T (1992) Neurotrophic action of gliostatin on cortical neurons: identity of gliostatin and platelet-derived endothelial cell growth factor. J Biol Chem 267:20311-20316
13. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S (1992) Angiogenic factor. Nature 356:668
14. Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
15. Hirano T, Asai K, Matsukawa K, Kato T, Takeuchi M, Yonezawa M, Otsuka T, Matsui N (1993) Establishment of enzyme immunoassay system for gliostatin/platelet-derived endothelial cell growth factor (PD-ECGF). Biochim Biophys Acta 1176:299-304
16. Muro H, Waguri-Nagaya Y, Otsuka T, Matsui N, Asai K, Kato T (2001) Serum gliostatin levels in patients with rheumatoid factor-negative and factor-positive rheumatoid arthritis and changes of these levels after surgical treatment. Clin Rheumatol 20:331-336
17. Colville-Nash PR, Scott DL (1992) Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 51:919-925
18. Seitz M, Dewald B, Ceska M, Gerber N, Baggiolini M (1992) Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 12:159-164
19. Loetscher P, Dewald B, Baggiolini M, Seitz M (1994) Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Cytokine 6:162-170
20. Deleuran B, Kristensen M, Paludan K, Zachariae C, Larsen CG, Zachariae E, Thestrup-Pedersen K (1992) The effect of second-line antirheumatic drugs on interleukin-8 mRNA synthesis and protein secretion in human endothelial cells. Cytokine 4:403-409
21. Yoshida S, Kato T, Sakurada S, Kurono C, Yang JP, Matsui N, Soji T, Okamoto T (1999) Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int Immunol 11:151-158
22. Mascarenhas BR, Granda JL, Freyberg RH (1972) Gold metabolism in patients with rheumatoid arthritis treated with gold compounds - reinvestigated. Arthritis Rheum 15:391-402
23. Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M (1999) Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79:1553-1563
24. Maeda K, Kang SM, Ogawa M, Onoda N, Sawada T, Nakata B, Kato Y, Chung YS, Sowa M (1997) Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma. Int J Cancer 74:545-550
25. O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, Harris AL (2000) Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer 82:1427-1432
26. Toi M, Inada K, Hoshina S, Suzuki H, Kondo S, Tominaga T (1995) Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res 1:961-964
27. Walsh DA (1999) Angiogenesis and arthritis. Rheumatology 38:103-12
28. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149-4156
29. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341-346
30. Nagashima M, Yoshino S, Ishiwata T, Asano G (1995) Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 22:1624-1630
31. Nagashima M, Yoshino S, Aono H, Takai M, Sasano M (1999) Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells. Clin Exp Immunol 116:360-365